Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
ELITE PHARMACEUTICALS INC (ELTP)
| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/06/2022 | Kirkov Kirko | Chief Commercial Officer | Grant | Options | 3M | $0.04 | $105k | | 11/10/2022 |
| 08/28/2022 | WHITNELL JEFFREY A | Director | Grant | Common Stock | 459.5k | $0.04 | $20k | | 08/28/2022 |
| 08/28/2022 | Caskey Davis S | Director | Grant | Common Stock | 459.5k | $0.04 | $20k | | 08/28/2022 |
| 08/28/2022 | Dash Barry H | Director | Grant | Common Stock | 459.5k | $0.04 | $20k | | 08/28/2022 |
| 05/16/2022 | Chen Robert C J | CFO, Secretary, Treasurer | Grant | Options | 900k | $0.04 | $36k | | 05/16/2022 |
| 06/30/2021 | Dash Barry H | Director | Grant | Common Stock | 295.6k | $0.07 | $20k | | 06/30/2021 |
| 06/30/2021 | Caskey Davis S | Director | Grant | Common Stock | 295.6k | $0.07 | $20k | | 06/30/2021 |
| 06/30/2021 | WHITNELL JEFFREY A | Director | Grant | Common Stock | 295.6k | $0.07 | $20k | | 06/30/2021 |
| 05/17/2021 | Bregman Marc | CFO, Secretary, Treasurer | Grant | Options | 300k | $0.06 | $16.9k | | 05/17/2021 |
| 08/24/2020 | Hakim Nasrat A | CEO & President | Conversion | Common Stock | 158M | $0.00 | $0 | | 08/24/2020 |
| 08/24/2020 | Hakim Nasrat A | CEO & President | Conversion | Series J Convertible Preferred Shares | 24.0344 | $0.00 | $0 | | 08/24/2020 |
| 08/20/2020 | Caskey Davis S | Director | Grant | Common Stock | 516.8k | $0.09 | $45k | | 08/20/2020 |
| 08/20/2020 | WHITNELL JEFFREY A | Director | Grant | Common Stock | 516.8k | $0.09 | $45k | | 08/20/2020 |
| 08/20/2020 | Plassche Douglas | SVP Operations | Grant | Common Stock | 71.7k | $0.09 | $6.3k | | 08/20/2020 |
| 08/20/2020 | Dash Barry H | Director | Grant | Common Stock | 516.8k | $0.09 | $45k | | 08/20/2020 |
| 06/30/2020 | Plassche Douglas | SVP Operations | Grant | Common Stock | 574.6k | $0.09 | $50k | | 06/30/2020 |
| 02/26/2018 | Pfeifer Eugene M | Director | Grant | Common Stock | 161.4k | $0.12 | $20k | | 02/26/2018 |
| 02/26/2018 | Plassche Douglas | SVP Operations | Grant | Common Stock | 201.7k | $0.12 | $25k | | 02/26/2018 |
| 02/26/2018 | Ward Carter Julian | CFO, Sec., Treas. | Grant | Common Stock | 242.1k | $0.12 | $30k | | 02/26/2018 |
| 02/26/2018 | Dash Barry H | Director | Grant | Common Stock | 161.4k | $0.12 | $20k | | 02/26/2018 |
| 02/26/2018 | Caskey Davis S | Director | Grant | Common Stock | 161.4k | $0.12 | $20k | | 02/26/2018 |
| 02/26/2018 | WHITNELL JEFFREY A | Director | Grant | Common Stock | 161.4k | $0.12 | $20k | | 02/26/2018 |
| 04/28/2017 | Hakim Nasrat A | CEO & President | Other (disposition) | Common Stock | 158M | $0.00 | $0 | | 04/28/2017 |
| 04/28/2017 | Hakim Nasrat A | CEO & President | Other (acquisition) | | 24.0344 | $1,000,000.00 | $24M | | 04/28/2017 |
| 04/28/2017 | Hakim Nasrat A | CEO & President | Other (acquisition) | Warrants | 79M | $0.15 | $12M | | 04/28/2017 |
| 02/23/2017 | Hakim Nasrat A | CEO & President | Grant | Common Stock | 2.2M | $0.23 | $499.9k | | 02/23/2017 |
| 02/23/2017 | Pfeifer Eugene M | Director | Grant | Common Stock | 72k | $0.20 | $14.6k | | 02/23/2017 |
| 02/23/2017 | Caskey Davis S | Director | Grant | Common Stock | 68.5k | $0.20 | $13.4k | | 02/23/2017 |
| 02/23/2017 | Dash Barry H | Director | Grant | Common Stock | 88.7k | $0.23 | $20k | | 02/23/2017 |
| 02/23/2017 | Plassche Douglas | SVP Operations | Grant | Common Stock | 110.8k | $0.23 | $25k | | 02/23/2017 |
| 02/23/2017 | Ward Carter Julian | CFO, Sec., Treas. | Grant | Common Stock | 133k | $0.23 | $30k | | 02/23/2017 |
| 02/23/2017 | WHITNELL JEFFREY A | Director | Grant | Common Stock | 88.7k | $0.23 | $20k | | 02/23/2017 |
| 08/17/2016 | Hakim Nasrat A | CEO & President | Exercise | | 100 | $0.00 | $0 | see footnote | 08/17/2016 |
| 04/28/2016 | Ward Carter Julian | CFO, Sec., Treas. | Conversion | Common Stock | 666.7k | $0.06 | $41.7k | | 04/28/2016 |
| 04/28/2016 | Ward Carter Julian | CFO, Sec., Treas. | Conversion | Warrants | 666.7k | $0.06 | $41.7k | | 04/28/2016 |
|
|